EAACI Congress 2023
BackFlash talks on asthma treatment
Friday 09 Jun, 16:45 PM -
18:15 PM CEST
Hall Y 09+10
Flash Talks
16:45
Real-world outcomes of patients with severe asthma treated with mepolizumab by baseline inhaled corticosteroid dose: post hoc analysis of REALITI-A at 2 years
16:52
Towards standardisation of clinical outcomes used in allergen immunotherapy in allergic asthma
16:59
Airway Epithelial Antiviral Immunity is Enhanced by Allergen Immunotherapy in Allergic Asthma
17:06
Evaluation of disease control after SARS-CoV-2 infection and/or vaccination in patients with NSAID-exacerbated respiratory disease
17:13
TMT-Based Quantitative Proteomic Analysis Reveals Downregulation of ITGAL and Syk by the Effects of Cycloastragenol in OVA-Induced Asthmatic Mice
17:20
Role of sex hormones in β2-receptor-mediated relaxation in bronchial tissue
17:27
The Comparison Study on Accuracy of the Novel Digital Peak Expiratory Flow Device Compared to Conventional Peak Flow Meters
17:34
Impact of Age of Asthma Onset on the Long-Term Efficacy of Dupilumab in Patients with Type 2 Inflammation: LIBERTY ASTHMA TRAVERSE study
17:41
Impact of single inhaler triple therapy in asthmatic patients lung function: experience of an Allergy and Clinical Immunology Unit
17:48
The effects of Derp6 and Cupa1 allergens on the different cell death pathways in bronchial and nasal epithelial cells
